胃癌腹膜转移中CAF-巨噬细胞交互对话主导免疫检查点阻断治疗反应
本研究为II期临床试验,纳入胃癌腹膜转移(GCPM)患者,采用信迪利单抗联合化疗,并对原发灶、腹膜转移灶及外周血行单细胞测序。结果发现GCPM以SPP1+肿瘤相关巨噬细胞和THBS2+基质癌相关成纤维细胞构成的基质-髓系生态位为主导,介导免疫检查点阻断(ICB)耐药;阻断C3-C3AR1轴可破坏该交互对话并改善ICB获益。
要点
- GCPM微环境由SPP1+TAM与THBS2+mCAF构成的基质-髓系生态位主导,区别于原发胃癌。
- THBS2+mCAF经补体C3-C3AR1招募腹膜特异性组织驻留巨噬细胞并促其转化为SPP1+TAM。
- 阻断C3-C3AR1轴可破坏基质-髓系交互对话,在体内模型中显著改善ICB获益。
核心结论
- GCPM中CAF-巨噬细胞交互对话是ICB耐药的主要介导者,阻断C3-C3AR1轴可改善ICB获益。
研究设计与样本
- II期临床试验,纳入接受信迪利单抗联合化疗的GCPM患者,采集原发灶、腹膜转移灶及外周血行单细胞测序。
主要发现
- GCPM生态系统形成以SPP1+TAM和THBS2+mCAF构成的基质-髓系生态位为主导的独特免疫抑制模式,不同于原发胃癌。
- 该基质-髓系交互对话是GCPM患者ICB耐药的主要介导者。
- THBS2+mCAF通过补体C3及其受体C3AR1促进腹膜特异性组织驻留巨噬细胞募集并转化为SPP1+TAM,形成促肿瘤生态位。
- 阻断C3-C3AR1轴可破坏基质-髓系交互对话,在体内模型中显著改善ICB获益。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Peritoneal metastasis is the most common metastasis pattern of gastric cancer. Patients with gastric cancer peritoneal metastasis (GCPM) have a poor prognosis and respond poorly to conventional treatments. Recently, immune checkpoint blockade (ICB) has demonstrated favourable efficacy in the treatment of GCPM. Stratification of best responders and elucidation of resistance mechanisms of ICB therapies are highly important and remain major clinical challenges. DESIGN: We performed a phase II trial involving patients with GCPM treated with ICB (sintilimab) combined with chemotherapy. The samples of primary tumours, GCPMs and peripheral blood from patients were collected for single-cell sequencing to comprehensively interpret the tumour microenvironment of GCPM and its impacts on immunotherapy efficacy. RESULTS: The GCPM ecosystem coordinates a unique immunosuppressive pattern distinct from that of primary GC, which is dominated by a stroma-myeloid niche composed of SPP1+tumour-associated macrophages (TAMs) and Thrombospondin 2 (THBS2)+matrix cancer-associated fibroblasts (mCAFs). Consequently, this stroma-myeloid crosstalk is the major mediator of ICB resistance in patients with GCPM. Mechanistically, the accumulated THBS2+mCAFs facilitate the recruitment of peritoneum-specific tissue-resident macrophages and their transformation into SPP1+TAMs via the complement C3 and its receptor C3a receptor 1 (C3AR1), thereby forming a protumoral stroma-myeloid niche. Blocking the C3-C3AR1 axis disrupts the stroma-myeloid crosstalk and thereby significantly improves the benefits of ICB in in vivo models. CONCLUSION: Our findings provide a new molecular portrait of cell compositions associated with ICB resistance in patients with GCPM and aid in the prioritisation of therapeutic candidates to potentiate immunotherapy.
引用
- Li Y, Zheng Y, Huang J, et al. CAF-macrophage crosstalk in tumour microenvironments governs the response to immune checkpoint blockade in gastric cancer peritoneal metastases. Gut. 2025. PMID: 39537239. doi:10.1136/gutjnl-2024-333617
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。